Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2009
11/19/2009WO2009139881A2 Compositions and methods for growing embryonic stem cells
11/19/2009WO2009139804A2 Biologically active recombinant human saposin c and psap
11/19/2009WO2009139703A1 Method for cell expansion
11/19/2009WO2009139419A1 Human hepatic stem cell, method for preparation of the same, method for induction of differentiation of the same, and method for utilization of the same
11/19/2009WO2009139413A1 Method for production of cell mass containing cytokine-induced killer cell
11/19/2009WO2009139392A1 PROCESS FOR PRODUCTION OF β-ALANYLAMINO ACID OR DERIVATIVE THEREOF
11/19/2009WO2009139365A1 Process for production of cis-4-hydroxy-l-proline
11/19/2009WO2009139177A1 Blood platelet induction method
11/19/2009WO2009138855A2 Methods and systems for the production of granulosa cells
11/19/2009WO2009138850A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
11/19/2009WO2009138489A1 Plasmacytoid dendritic cell line used in active or adoptive cell therapy
11/19/2009WO2009137874A1 Method of inducing proliferation and/or differentiation of neural precursor cells by introducing prolactin or wnt3a to activate latent neural precursor cells
11/19/2009WO2009049734A3 Cosmetic method for increasing the pigmentation of the skin using melanocyte precursor cells
11/19/2009WO2009040413A3 An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
11/19/2009WO2008129422A8 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
11/19/2009WO2003064450A9 Epizootic catarrhal enteritis prevention, treatment and diagnosis
11/19/2009US20090288232 expression cassette comprising a polynucleotide encoding an alpha-amylase that are optimized for expression in plants; transgenic plants to produce food products having improved taste; produce fermentable substrates for the production of ethanol and fermented beverages
11/19/2009US20090288228 Plants having improved growth characteristics and a method for making the same
11/19/2009US20090288225 Novel Aromatic Acyltransferase Genes
11/19/2009US20090288217 Highly Transformable Elite Doubled Haploid Line PHWVZ
11/19/2009US20090288216 Plants and seeds of hybrid corn variety ch744092
11/19/2009US20090288215 Plants and seeds of hybrid corn variety ch546505
11/19/2009US20090288214 Genetic system for controlling the floral development of a dicotyledon plant, and implementation in detection and selection processes
11/19/2009US20090288213 Plants and seeds of hybrid corn variety ch872467
11/19/2009US20090288212 Plants and seeds of hybrid corn variety ch440457
11/19/2009US20090288211 Plants and seeds of hybrid corn variety ch408813
11/19/2009US20090288210 Plants and seeds of hybrid corn variety ch951965
11/19/2009US20090288200 Plants and seeds of hybrid corn variety ch904217
11/19/2009US20090288191 Plants and seeds of hybrid corn variety ch897363
11/19/2009US20090288178 Insect cell line for production of recombinant glycoproteins with sulfated complex n-glycans
11/19/2009US20090288176 Novel Gene Disruptions, Compositions and Methods Relating Thereto
11/19/2009US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009US20090286958 Interferon-beta fusion proteins and uses
11/19/2009US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009US20090286853 Modified oligonucleotides for telomerase inhibition
11/19/2009US20090286851 Compositions and Methods for Delivering RNAI Using Lipoproteins
11/19/2009US20090286847 Oncogenic ras-specific cytotoxic compound and methods of use thereof
11/19/2009US20090286767 Substituted quinolin-4-ylamine analogues
11/19/2009US20090286748 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090286738 Gene Regulation
11/19/2009US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090286733 Long-acting veterinary polypeptides and methods of producing and administering same
11/19/2009US20090286727 DP-78-Like Nanobodies
11/19/2009US20090286720 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin
11/19/2009US20090286714 Novel molecules of the card-related protein family and uses thereof
11/19/2009US20090286695 Luminescent stem cells and uses thereof
11/19/2009US20090286320 Site-specific recombination in eukaryotes and constructs useful therefor
11/19/2009US20090286318 Modules for Membrane Aeration
11/19/2009US20090286317 Modular culture system for maintenance, differentiation and proliferation of cells
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090286315 Process for preserving insulin-secreting cells intended to be transplanted in a patient
11/19/2009US20090286314 Fluorescent proteins and genes encoding them
11/19/2009US20090286313 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
11/19/2009US20090286312 Methods and Compositions for Treating Allergic Diseases
11/19/2009US20090286301 Extraction of biomolecular complexes assisted by alternating hydrostatic pressure
11/19/2009US20090286283 Method and affinity column for purifying proteins
11/19/2009US20090286281 Secretase for use in identifying modulator for treatment and prevention of alzheimers disease; Beta-site amyloid precursor protein cleaving enzyme (BACE)
11/19/2009US20090286278 Multi-layer cell encapsulation for tissue engineering
11/19/2009US20090286265 Cripto Blocking Antibodies And Uses Thereof
11/19/2009US20090286262 Nucleic acid, polypeptide and its use
11/19/2009US20090286259 Screening method for gpcr ligands
11/19/2009US20090286224 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
11/19/2009US20090286221 Device Comprising a Container System for a Bodily Fluid
11/19/2009US20090285892 Methods and systems for expanding ac133+ cells and directing differentiation
11/19/2009US20090285886 Enhanced antimicrobial activity of plant essential oils
11/19/2009US20090285883 Identification of gastrointestinal, pancreatic and cancer stem cell markers and methods of use thereof
11/19/2009US20090285860 Cancer immunotherapy
11/19/2009US20090285852 Expression System Incorporating a Capsid Promotor Sequence as an Enhancer of a Cytomegalovirus Promotor
11/19/2009US20090285843 Epitope sequences
11/19/2009US20090285842 Immune privileged and modulatory progenitor cells
11/19/2009US20090285835 Antibodies which bind human CXCR3
11/19/2009US20090285831 Immunointeractive molecules
11/19/2009US20090285830 Antibodies to lymphotoxin-alpha
11/19/2009US20090285824 immunoglobulins; humanizing; chimera; fragments; complementary determining regions; breast cancer
11/19/2009US20090285818 Cripto Blocking Antibodies and Uses Thereof
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection
11/19/2009US20090285814 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
11/19/2009US20090285812 human P-selectin glycoprotein ligand 1 (PSGL-1) monoclonal antibodies which block both selectin and chemokine binding to PSGL-1 expressed on leukocytes, lymphocytes and endothelial cells; inflammation such as inflammatory bowel disease
11/19/2009US20090285810 Humanized anti-tgf-beta antibodies
11/19/2009US20090285806 Methods and compositions for improving recombinant protein production
11/19/2009US20090285805 Binding molecules
11/19/2009US20090285803 ANTI-PirB ANTIBODIES
11/19/2009US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using
11/19/2009US20090285799 Antibody Antagonists of Interleukin-13 Receptor Alpha1
11/19/2009US20090285796 Mutant jak3 kinase in human leukemia
11/19/2009US20090285788 RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME
11/19/2009US20090285786 Method to modulate hematopoietic stem cell growth
11/19/2009US20090285779 Induction of apoptosis in toll-like receptor expressing tumor cells
11/19/2009US20090285771 Methods and compositions for needleless delivery of macromolecules
11/19/2009US20090285757 Methods of targeting cells for diagnosis and therapy
11/19/2009US20090285754 Peptides for targeting apoptotic cells and uses thereof
11/19/2009US20090285751 Cancerous disease modifying antibodies
11/19/2009US20090285750 Agent, composition and method
11/19/2009DE102006039646B4 In-vitro-Herstellung von schläuchchenförmigen Blutgefäßendothelien In vitro production of schläuchchenförmigen Blutgefäßendothelien
11/19/2009DE10021627B4 Verfahren zur Herstellung eines vaskularisierten bioartifiziellen Gewebes und zugehöriger Versuchsreaktor A method for producing a bioartificial vascularized tissue and associated experimental reactor
11/19/2009CA2724071A1 Plasmacytoid dendritic cell line used in active or adoptive cell therapy
11/19/2009CA2724043A1 Blood platelet induction method
11/19/2009CA2723973A1 Anti-fn14 antibodies and uses thereof
11/19/2009CA2722968A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 1827